基本信息:
- 专利标题: T型カルシウムチャネル阻害剤
- 申请号:JP2019028168 申请日:2019-07-17
- 公开(公告)号:JPWO2020017569A1 公开(公告)日:2021-12-02
- 发明人: 田中 博人 , 大井 勲 , 齊藤 大祐 , 林田 康平 , 山元 広平 , 川畑 篤史
- 申请人: 日本ケミファ株式会社 , 学校法人近畿大学
- 申请人地址: 東京都千代田区岩本町2丁目2番3号
- 专利权人: 日本ケミファ株式会社,学校法人近畿大学
- 当前专利权人: 日本ケミファ株式会社,学校法人近畿大学
- 当前专利权人地址: 東京都千代田区岩本町2丁目2番3号
- 代理人: 棚井 澄雄; 大槻 真紀子
- 优先权: JP2018134402 2018-07-17
- 主分类号: A61P43/00
- IPC分类号: A61P43/00 ; A61P9/10 ; A61P17/04 ; A61P37/08 ; A61P9/12 ; A61P5/40 ; A61P27/02 ; A61P35/00 ; A61P3/10 ; A61P15/00 ; A61P9/06 ; A61P13/12 ; A61P25/08 ; A61P25/14 ; A61P25/18 ; A61P25/16 ; A61P25/24 ; A61P25/22 ; A61P25/28 ; A61P25/30 ; A61P25/20 ; A61P13/10 ; A61P25/04 ; C07D401/04 ; A61K31/4439 ; C07D401/14 ; C07D403/04 ; A61K31/506 ; C07D417/04 ; A61K31/427 ; A61K31/501 ; A61K31/541 ; C07D413/14 ; A61K31/5377 ; C07D491/107 ; A61K31/497 ; A61K31/4709 ; A61K31/496 ; C07D491/113 ; C07D409/04 ; A61K31/4025 ; C07D207/14 ; C07D498/08 ; A61K31/5386 ; C07D491/08 ; A61K31/397 ; A61K31/40 ; A61K31/4184 ; A61K31/444 ; C07D471/04 ; A61K31/437 ; C07D411/14 ; C07D403/12 ; C07D403/14 ; A61K31/517 ; A61K31/4545 ; C07D401/12 ; A61K31/454 ; A61K31/428 ; C07D413/04 ; A61K31/422 ; A61K31/402 ; C07D205/04
To provide a novel T-type calcium channel blocker.A compound represented by the following General Formula (I), a tautomer or a stereoisomer of the compound, a pharmaceutically acceptable salt of the compound, or a solvate of the compound, the tautomer, the stereoisomer, or the salt is used as a T-type calcium channel blocker.wherein A represents a phenyl which may have a substituent, a 4-membered to 6-membered heteroaryl ring composed of one to three identical or different heteroatoms selected from an oxygen atom, a sulfur atom, and a nitrogen atom and carbon atoms as ring-constituting atoms, or a heterocondensed ring composed of the heteroaryl ring and either a benzene ring or a 6-membered heteroaryl ring composed of one to two nitrogen atoms and carbon atoms, wherein the heteroaryl ring or the heterocondensed ring may have a substituent and is bonded to a nitrogen atom of the adjacent cyclic amino by means of a carbon atom constituting these rings;B represents a phenyl which may have a substituent, a 5-membered or 6-membered heteroaryl ring composed of one to three identical or different heteroatoms selected from an oxygen atom, a sulfur atom, and a nitrogen atom and carbon atoms as ring-constituting atoms, or a heterocondensed ring composed of the heteroaryl ring and either a benzene ring or a 6-membered heteroaryl ring composed of one to two nitrogen atoms and carbon atoms, wherein the heteroaryl ring or the heterocondensed ring may have a substituent and is bonded to the adjacent cyclopropyl ring by means of a carbon atom constituting these rings;R1 and R2, which may be identical or different, each represent a hydrogen atom, a halogen atom, or the like;R3 represents a hydrogen atom, a halogen atom, or the like;n and m, which may be identical or different, each represent 0 or 1; and p represents 1 or 2.
公开/授权文献:
- JP2020136496A 電子デバイス、電子デバイスの製造方法およびリード 公开/授权日:2020-08-31
信息查询:
EspacenetIPC结构图谱:
A | 人类生活必需 |
--A61 | 医学或兽医学;卫生学 |
----A61P | 化合物或药物制剂的治疗活性 |
------A61P43/00 | 在A61P1/00到A61P41/00组中不包含的,用于特殊目的的药物 |